Back to top

Image: Shutterstock

Company News for Aug 4, 2022

Read MoreHide Full Article
  • Shares of Moderna, Inc. (MRNA - Free Report) surged 16% after it announced a $3 billion share buyback plan.
  • Regeneron Pharmaceuticals, Inc.’s (REGN - Free Report) shares rose 5.9% after it reported second-quarter 2022 earnings of $9.77 per share, beating the Zacks Consensus Estimate of $8.53 per share.
  • Shares of Horizon Therapeutics Public Limited Company plummeted 18.5% after it reported second-quarter 2022 revenues of $876.4 million, missing the Zacks Consensus Estimate of $938.8 million.
  • Exelon Corporation’s (EXC - Free Report) shares fell 3.3% after it reported second-quarter 2022 earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.46 per share.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Regeneron Pharmaceuticals, Inc. (REGN) - free report >>

Exelon Corporation (EXC) - free report >>

Moderna, Inc. (MRNA) - free report >>

Published in

pharmaceuticals